Acceptance of Vaccination Associated with Lower Social Media Use and Higher Trust in Government
Vaccination is generally considered an essential tool for curbing the COVID-19 pandemic. Although Russia was one of the first countries to develop a vaccine against COVID-19 and launched an immunisation campaign in 2021, its vaccination rates remained low for a long time. By October 2021, only 36% of Russian adults were vaccinated, many of whom were compelled by their employers to do so. Having examined the factors contributing to low trust in vaccination among Russians, HSE economists suggest measures to improve vaccination uptake. The paper is published in Vaccine.
The paper uses data from the 29th wave of HSE's Russia Longitudinal Monitoring Survey (RLMS-HSE), conducted in the autumn of 2020. The survey respondents were asked, 'Are you planning to get vaccinated against COVID-19 once a vaccine becomes available?'.
No particular vaccine was mentioned, as all vaccine candidates were then at the trial stage. The answers, therefore, reflect the respondents' general attitudes towards vaccination. It was found that only 8% of respondents would ‘certainly’ get vaccinated, 36% would get a vaccine only if they were convinced of its safety and reliability, 44% did not intend to get vaccinated at all, and 13% were not sure. The responses reveal a high degree of resistance to vaccination even before any vaccine became available, and also a degree of ‘conditional acceptance’, as more than a third of respondents made their vaccination decision conditional on the future vaccine's quality.
This is the first paper in Russia to use multivariate econometric modelling to pinpoint the key determinants of COVID-19 vaccination attitudes on a sample of 8529 Russians aged 18 and older.
The advantage of RLMS-HSE is that it is not limited to standard socio-demographic data, but covers a wide range of individual characteristics, such as the use of social media, religiosity, and trust in government institutions. These characteristics, as well as the COVID-19 incidence rate in each surveyed region (measured as a 7-day moving average preceding the day of the survey), were included as independent variables in the regression model that revealed significant differences across four categories of respondents. While no differences in gender or income were observed, those who absolutely rejected vaccination included both younger and older respondents who self-rated their health as either 'very good' or 'very bad'.
Vaccine rejectors were also likely to have a lower level of education and a higher risk tolerance, and to live in Moscow or St Petersburg. Compared to those who would 'conditionally accept' a vaccine, rejectors reported higher levels of both neuroticism and agreeableness and had a higher proportion of those who never attended church as well as those who attended church at least once a month. They also reported less trust in government institutions and estimated their risk of contracting COVID-19 as low.
Those prepared to accept vaccination unconditionally reported the highest level of trust in government and rarely used social media. This finding may be significant, since social media served as an important source of information about COVID-19 vaccines, although they often spread anti-vax conspiracy rumours. Compared to 'conditional accepters', rejectors tend to be more friendly but less extroverted, and slightly more likely to be atheists. People who have already had COVID-19 are also more likely to be found in the 'rejector' group.
The researchers conclude that attitudes towards vaccination are shaped by a variety of socio-economic and personality factors, including one's risk appetite and trust in government.
The authors also suggest that vaccination-promoting policies need to take into account the observed distinctions across these four groups.
Yana Roshchina, Leading Research Fellow of the HSE Institute for Social Policy and Senior Research Fellow of the HSE Laboratory for Studies in Economic Sociology
'Perhaps hard data on vaccine effectiveness and safety could help convince those who hesitate, while those who reject vaccination altogether need a different approach. They may be generally lacking vaccine literacy; therefore, educating them about achievements in science and medicine could improve vaccination uptake in this group.'
Yana Roshchina
Senior Research Fellow, Laboratory for Studies in Economic Sociology
See also:
Paper by HSE Biologists Included in the Top 5 Popular Articles of PeerJ Journal
An article by researchers from HSE University’s Faculty of Biology and Biotechnology is among the most read articles published in the PeerJ journal in 2023. In the paper, the researchers establish a link between the genetic characteristics of the human immune system and its ability to effectively resist new waves of COVID-19. PeerJ is a peer-reviewed open access scientific journal covering research in the field of biological and medical sciences. Every year the editors compile a ranking of the most popular scientific papers.
HSE Researchers Find Out How to Communicate Health Information More Effectively to Fight COVID-19
Focusing on mortality from the COVID-19 virus is no more effective than calls to wear masks and save lives, but it significantly increases people's anxiety. After conducting an experiment with over 15,000 respondents from 84 countries, an international group of researchers, including scientists from HSE, came to this conclusion. The results of the study have been published in the Affective Science journal.
COVID-19 Mortality Highest in More Affluent Russian Regions
COVID-19 came as an unexpected challenge for humanity. Countries adopted different, sometimes diametrically opposed approaches to minimising the pandemic's impact: from hard lockdowns to no restrictions at all, as in Sweden. It was only last week that China began to relax its zero-tolerance policy. Researchers of the HSE Faculty of Economic Sciences have identified a few factors which tend to have the greatest impact on the spread of COVID-19—in Russia, such factors include ambient humidity and temperatures, population mobility, the share of internal migrants in the local population, and household incomes. The study findings are published in Population and Economics.
Russian Researchers Assess the Power of T-Cell Immune Response to Omicron BA.1 and BA.2
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron variant of SARS-CoV-2. In approximately 90% of vaccinated Europeans, T-cell immunity was as effective against Omicron as with other variants. The results of the study were published in PeerJ.
Russian Researchers Assessed the Likelihood of Sleep Disorders after COVID-19
A team of researchers from the HSE Centre for Cognition and Decision Making and the Central State Medical Academy conducted a study on sleep disorders, mood and fatigue after COVID-19. These factors are interrelated and the researchers recommend a comprehensive approach to treat the problem effectively. The work was published in the journal Neuroscience and Behavioral Psychology.
HSE Biologists Prepare Strategy for Universal COVID Test
Russian researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification. According to their publication in Applied Biochemistry and Microbiology, use of this strategy will make it possible to create universal test systems for any of the COVID-19 variants.
HSE University Researchers Investigate Why Many Russians Oppose Vaccination
Despite the risks associated with COVID-19 infection, many Russians either refuse to get vaccinated or are uncertain and hesitant about the practice. The factors behind these views are the subject of research by Yana Roshchina, Leading Research Fellow of the HSE University Centre for Longitudinal Studies and Senior Research Fellow of the Laboratory for Studies in Economic Sociology (LSES); Sergey Roshchin, Head of the Laboratory for Labour Market Studies (LLMS) and HSE University Vice Rector; and Ksenia Rozhkova, Junior Research Fellow at LLMS. The results of the study were presented at an LSES seminar.
Vaccines as a Profession: ICEF Graduate Talks about His Work at Sanofi Pasteur
Nikolay Kuzin, a 2011 graduate of ICEF, is brand manager at Sanofi Pasteur (France), a company that has been manufacturing vaccines for many years and where he oversees the launch of new products in Eastern European markets. We spoke with Nikolay about how he combines the background in finance with the administrative responsibilities in his position, about the unique nature of French master’s programmes, about how long it really takes to develop a vaccine, and about why Europeans trust medical developments in their countries.
New Safety Measures to Be Introduced at HSE University
Starting September 1, 2021, HSE University-Moscow is introducing new safety policies on campus to prevent the spread of COVID-19. They apply to students over 18 years old who have not had COVID during the last six months, have not been vaccinated (with a Russian or a foreign vaccine), nor have a medical exemption from vaccination. Free vaccination will be available on campus to all arriving students.